HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corrado Tarella Selected Research

Primary Myelofibrosis (Myelosclerosis)

7/2013Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Corrado Tarella Research Topics

Disease

20Lymphoma (Lymphomas)
08/2023 - 09/2002
11Neoplasms (Cancer)
11/2022 - 01/2002
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2023 - 03/2005
7Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2019 - 09/2002
6Hodgkin Disease (Hodgkin's Disease)
01/2024 - 06/2003
6B-Cell Lymphoma (Lymphoma, B Cell)
02/2021 - 01/2006
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 11/2011
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2021 - 07/2003
4Residual Neoplasm
01/2020 - 04/2003
4Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2013 - 03/2005
3Pathologic Complete Response
01/2021 - 01/2002
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020 - 01/2010
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2018 - 07/2012
2Anemia
01/2024 - 04/2020
2Ovarian Epithelial Carcinoma
11/2022 - 01/2021
2Cytopenia
11/2022 - 09/2005
2COVID-19
01/2022 - 02/2021
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2015 - 01/2006
2Liver Cirrhosis (Hepatic Cirrhosis)
10/2013 - 07/2006
2Disease Progression
07/2012 - 02/2011
2Myocardial Infarction
04/2006 - 02/2006
2Graft vs Host Disease (Graft-Versus-Host Disease)
06/2004 - 01/2002
1Infections
01/2022
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2022
1Pleural Effusion (Pleural Effusions)
02/2021
1Chest Pain (Chest Pains)
02/2021
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2021
1Dyspnea (Shortness of Breath)
02/2021
1Pneumonia (Pneumonitis)
02/2021
1Cough
02/2021
1Hematologic Diseases (Blood Diseases)
01/2021
1Monoclonal Gammopathy of Undetermined Significance
01/2021
1Respiratory Insufficiency (Respiratory Failure)
04/2020
1Thrombocytopenia (Thrombopenia)
04/2020
1Nervous System Diseases (Neurological Disorders)
01/2020
1Neuroinflammatory Diseases
01/2020
1Melanoma (Melanoma, Malignant)
04/2015
1Fibrosis (Cirrhosis)
10/2013
1Primary Myelofibrosis (Myelosclerosis)
07/2013
1Polycythemia Vera
07/2013
1Hemolytic Anemia
04/2013
1Pilonidal Sinus (Pilonidal Cyst)
10/2012
1Wounds and Injuries (Trauma)
10/2012

Drug/Important Bio-Agent (IBA)

13Rituximab (Mabthera)FDA Link
11/2019 - 07/2003
8Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 02/2006
5Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020 - 10/2007
4Biomarkers (Surrogate Marker)IBA
10/2023 - 07/2013
4Vincristine (Oncovin)FDA LinkGeneric
10/2018 - 10/2007
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2017 - 01/2002
3venetoclaxIBA
01/2023 - 01/2020
3Prednisone (Sone)FDA LinkGeneric
02/2017 - 10/2007
2Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2022 - 01/2021
2Vinblastine (Vinblastine Sulfate)FDA Link
11/2020 - 10/2018
2Dacarbazine (DIC)FDA LinkGeneric
11/2020 - 10/2018
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2018 - 06/2012
2AntimetabolitesIBA
11/2018 - 11/2015
2Methotrexate (Mexate)FDA LinkGeneric
11/2015 - 06/2004
2CytokinesIBA
04/2015 - 02/2011
2Alemtuzumab (Campath)FDA Link
10/2007 - 01/2006
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2006 - 02/2006
2fludarabineIBA
01/2006 - 01/2002
1Azacitidine (5 Azacytidine)FDA Link
01/2022
1AnthracyclinesIBA
01/2022
1dimemorfan (AT 17)IBA
02/2021
1Tyrosine Kinase InhibitorsIBA
02/2021
1Dasatinib (BMS 354825)FDA Link
02/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
11/2020
1Filgrastim (Neupogen)FDA Link
01/2020
1Ribosomal Proteins (Ribosomal Protein)IBA
01/2019
1Calcineurin InhibitorsIBA
11/2018
1Etoposide (VP 16)FDA LinkGeneric
11/2015
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2015
1Melanoma-Specific AntigensIBA
04/2015
1AntigensIBA
04/2015
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2015
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
04/2015
1Surface Antigens (Surface Antigen)IBA
04/2015
1Bendamustine HydrochlorideFDA Link
04/2013
1AgglutininsIBA
04/2013
1Sorafenib (BAY 43-9006)FDA Link
07/2012
1Immunoglobulins (Immunoglobulin)IBA
06/2012
1Inosine Triphosphate (ITP)IBA
06/2012
1SteroidsIBA
06/2012

Therapy/Procedure

28Drug Therapy (Chemotherapy)
01/2024 - 09/2002
18Therapeutics
01/2024 - 06/2003
8Radiotherapy
01/2022 - 09/2005
6Stem Cell Transplantation
01/2024 - 03/2005
6Autologous Transplantation
04/2008 - 09/2002
4Salvage Therapy
01/2024 - 01/2005
4Immunotherapy
10/2021 - 06/2011
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2015 - 03/2005
3Homologous Transplantation
03/2005 - 01/2002
2Aftercare (After-Treatment)
01/2022 - 01/2020
2Transplantation
01/2021 - 01/2002
1Kidney Transplantation
01/2021
1Chemoradiotherapy
04/2020
1Hematopoietic Stem Cell Transplantation
08/2013
1Splenectomy
06/2012